Download presentation
Presentation is loading. Please wait.
1
Volume 65, Issue 4, Pages 1408-1415 (April 2004)
Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients George A. Kaysen, Joel A. Dubin, Hans-Georg Müller, Laura Rosales, Nathan W. Levin, William E. Mitch, the HEMO Study Group Kidney International Volume 65, Issue 4, Pages (April 2004) DOI: /j x Copyright © 2004 International Society of Nephrology Terms and Conditions
2
Figure 1 Changes in the rate of albumin synthesis. Changes were measured as the turnover rate of [125]I human serum albumin measured during a 6-week period at baseline and either after a decline in serum albumin concentration of ≥0.3g/dL (left panel) or following 2years if serum albumin concentration did not decline by 0.3g/dL (right panel). Kidney International , DOI: ( /j x) Copyright © 2004 International Society of Nephrology Terms and Conditions
3
Figure 2 Changes in the levels of C-reactive protein (CRP) (A), ceruloplasmin (B), and α1 acid glycoprotein (α1AG) (C) in the 21 patients in whom albumin concentration declined by ≥0.3g/dL. Kidney International , DOI: ( /j x) Copyright © 2004 International Society of Nephrology Terms and Conditions
4
Figure 3 Levels of C-reactive protein (CRP) (A), ceruloplasmin (B), and α1 acid glycoprotein (α1AG) (C) during the two periods during which albumin synthesis was measured in the 38 patients in whom albumin concentration did not change (stable). Kidney International , DOI: ( /j x) Copyright © 2004 International Society of Nephrology Terms and Conditions
5
Figure 4 Equalibrated normalized protein catabolic rate (enPCR) measured during the periods of determination of albumin synthesis rate in the patients in whom albumin concentration declined by ≥0.3g/dL (A) and in those patients in whom albumin concentration remained unchanged (B). Kidney International , DOI: ( /j x) Copyright © 2004 International Society of Nephrology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.